Where Will Tenaya Therapeutics Inc (TNYA) Stock Go Next After It Has Risen 31.76% in a Week?

The market has been high on Tenaya Therapeutics Inc (TNYA) stock recently. TNYA gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Tenaya Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TNYA!

See Full TNYA Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TNYA Stock Today?

Tenaya Therapeutics Inc (TNYA) stock has fallen -1.41% while the S&P 500 is up 0.37% as of 12:48 PM on Monday, Feb 12. TNYA has fallen -$0.08 from the previous closing price of $5.68 on volume of 557,933 shares. Over the past year the S&P 500 has risen 21.94% while TNYA is up 87.29%. TNYA lost -$1.89 per share in the over the last 12 months. To screen for more stocks like Tenaya Therapeutics Inc click here.

More About Tenaya Therapeutics Inc

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Click Here to get the full Stock Report for Tenaya Therapeutics Inc stock.